Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide

Author： Gerstner Elizabeth   Eichler April   Plotkin Scott   Drappatz Jan   Doyle Colin   Xu Lei   Duda Dan   Wen Patrick   Jain Rakesh   Batchelor Tracy  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.103, Iss.2, 2011-06, pp. : 325-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

By Peereboom David   Shepard Dale   Ahluwalia Manmeet   Brewer Cathy   Agarwal Neeraj   Stevens Glen   Suh John   Toms Steven   Vogelbaum Michael   Weil Robert   Elson Paul   Barnett Gene  

Journal of Neuro-Oncology, Vol. 98, Iss. 1, 2010-05 ,pp. : 93-99

Springer Publishing Company

Access to resources Recommend Favorite

P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy

By Oberndorfer Stefan   Piribauer Maria   Marosi Christine   Lahrmann Heinz   Hitzenberger Peter   Grisold Wolfgang  

Journal of Neuro-Oncology, Vol. 72, Iss. 3, 2005-05 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas

By Raizer Jeffrey   Grimm Sean   Rademaker Alfred   Chandler James   Muro Kenji   Helenowski Irene   Rice Laurie   McCarthy Katie   Johnston Sandra   Mrugala Maciej   Chamberlain Marc  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 93-101

Springer Publishing Company

Access to resources Recommend Favorite

Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases

By Lee Lucy   Sharma Sunil   Morgan Bruno   Allegrini Peter   Schnell Christian   Brueggen Josef   Cozens Robert   Horsfield Mark   Guenther Clemens   Steward Will   Drevs Joachim   Lebwohl David   Wood Jeanette   McSheehy Paul  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 761-771

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

By Balaña Carmen   López-pousa Antonio   Berrocal Alfonso   Yaya-tur Ricardo   Herrero Ana   García Jose-luis   Martín-broto Javier   Benavides Manuel   Cerdá-nicolás Miguel   Ballester Rosa   Balart Josep   Capellades Jaume  

Journal of Neuro-Oncology, Vol. 70, Iss. 3, 2004-12 ,pp. : 359-370

Springer Publishing Company

Access to resources Recommend Favorite